The Role of NAD+ and NAD+-Boosting Therapies in Inflammatory Response by IL-13 is a research paper published in Pharmaceuticals (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of General Medical Sciences
Grant: 3P20GM103408
National Institute of General Medical Sciences
Grant: P20GM109095
National Institute of General Medical Sciences
Grant: R15HL165397
NIGMS NIH HHS
Grant: 3P20GM103408-23S1
NIGMS NIH HHS
Grant: P20 GM103408
National Institutes of Health
Grant: 3P20GM109095-08S1
Center of Biomedical Research Excellence in Matrix Biology Phase II
National Institutes of Health
Grant: 1R15HL165397-01
Harnessing endothelial cell transdifferentiation for cardiovascular therapy
National Institutes of Health
Grant: 5P20GM103408-16
Idaho INBRE Program
Biomolecular Research Center at Boise State University and Boise State University
FWCI
1.54
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals